Quantum Genomics Eo Stock Net Income
| 2QG Stock | EUR 0.07 0.00 0.00% |
QUANTUM GENOMICS EO technical analysis gives you tools to exploit past data patterns in attempt to determine a pattern that determines the direction of the company's future prices.
QUANTUM GENOMICS's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing QUANTUM GENOMICS's valuation are provided below:Gross Profit -1.1 M | Market Capitalization 4.5 M | Enterprise Value Revenue 11.062 | Revenue | Earnings Share (0.80) |
QUANTUM |
QUANTUM GENOMICS 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to QUANTUM GENOMICS's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of QUANTUM GENOMICS.
| 11/08/2025 |
| 02/06/2026 |
If you would invest 0.00 in QUANTUM GENOMICS on November 8, 2025 and sell it all today you would earn a total of 0.00 from holding QUANTUM GENOMICS EO or generate 0.0% return on investment in QUANTUM GENOMICS over 90 days. QUANTUM GENOMICS is related to or competes with Charter Communications, Citic Telecom, Gamma Communications, Entravision Communications, and Bank of America. Quantum Genomics Socit Anonyme, a biopharmaceutical company, develops drugs to treat cardiovascular diseases More
QUANTUM GENOMICS Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure QUANTUM GENOMICS's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess QUANTUM GENOMICS EO upside and downside potential and time the market with a certain degree of confidence.
QUANTUM GENOMICS Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for QUANTUM GENOMICS's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as QUANTUM GENOMICS's standard deviation. In reality, there are many statistical measures that can use QUANTUM GENOMICS historical prices to predict the future QUANTUM GENOMICS's volatility.QUANTUM GENOMICS Backtested Returns
We have found three technical indicators for QUANTUM GENOMICS, which you can use to evaluate the volatility of the company. The company owns a Beta (Systematic Risk) of 0.0, which implies not very significant fluctuations relative to the market. the returns on MARKET and QUANTUM GENOMICS are completely uncorrelated.
Auto-correlation | 0.00 |
No correlation between past and present
QUANTUM GENOMICS EO has no correlation between past and present. Overlapping area represents the amount of predictability between QUANTUM GENOMICS time series from 8th of November 2025 to 23rd of December 2025 and 23rd of December 2025 to 6th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of QUANTUM GENOMICS price movement. The serial correlation of 0.0 indicates that just 0.0% of current QUANTUM GENOMICS price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, QUANTUM GENOMICS EO reported net income of (11.54 Million). This is 103.38% lower than that of the Biotechnology sector and 116.47% lower than that of the Health Care industry. The net income for all Germany stocks is 102.02% higher than that of the company.
QUANTUM Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses QUANTUM GENOMICS's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of QUANTUM GENOMICS could also be used in its relative valuation, which is a method of valuing QUANTUM GENOMICS by comparing valuation metrics of similar companies.QUANTUM GENOMICS is currently under evaluation in net income category among its peers.
QUANTUM Fundamentals
| Return On Equity | -1.57 | ||||
| Return On Asset | -0.45 | ||||
| Current Valuation | 6.7 M | ||||
| Shares Outstanding | 69.71 M | ||||
| Shares Owned By Insiders | 3.35 % | ||||
| Shares Owned By Institutions | 5.80 % | ||||
| Price To Book | 0 X | ||||
| Price To Sales | 451,017 X | ||||
| Revenue | 10 | ||||
| Gross Profit | (1.15 M) | ||||
| EBITDA | (1.47 M) | ||||
| Net Income | (11.54 M) | ||||
| Cash And Equivalents | 27.15 M | ||||
| Cash Per Share | 1.01 X | ||||
| Total Debt | 1.87 K | ||||
| Current Ratio | 4.73 X | ||||
| Book Value Per Share | (0.04) X | ||||
| Cash Flow From Operations | (11.96 M) | ||||
| Earnings Per Share | (0.80) X | ||||
| Beta | -0.18 | ||||
| Market Capitalization | 4.51 M |
About QUANTUM GENOMICS Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze QUANTUM GENOMICS EO's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of QUANTUM GENOMICS using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of QUANTUM GENOMICS EO based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Other Information on Investing in QUANTUM Stock
QUANTUM GENOMICS financial ratios help investors to determine whether QUANTUM Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in QUANTUM with respect to the benefits of owning QUANTUM GENOMICS security.